OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/13/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization26,281 mln
Float1,791 mln
Earnings Date04/27/2026
EPS
1.04
Decent
P / E
14.46
Fair value
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.46
Borderline
1-Year Forecast
19.00
Strong upside
Relative Strength
68
/ 100
Outperforming
Business Description
Astellas Pharma is a Japan-based pharmaceutical company that develops and sells medicines for serious conditions including prostate cancer, leukemia, kidney disease, and menopause-related symptoms, among others. The company serves patients across oncology, urology, ophthalmology, immunology, and women's health, distributing its products both domestically and around the world. Astellas also works with external partners to advance new treatment approaches, including RNA-based therapies and diabetes management tools. Founded in 1923 and headquartered in Chuo, Japan, the company has built a broad portfolio of specialty medicines over its century-long history.
